Condition
Herpes Simplex Keratitis
Total Trials
4
Recruiting
1
Active
1
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 90/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
50% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 1 (1)
P 4 (1)
Trial Status
Terminated1
Unknown1
Recruiting1
Completed1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07329686Phase 1RecruitingPrimary
Clinical Study of Intrastromal Anti-VEGF Injection for Corneal Neovascularization.
NCT03217474Not ApplicableUnknownPrimary
Femtosecond Laser-assisted Corneal Debridement for Herpes Simplex Keratitis
NCT02045082Phase 4TerminatedPrimary
The Flocked Swab and the Traditional Fiber Swab for the Diagnosis of the Herpes Simplex Epithelial Keratitis
NCT00357812CompletedPrimary
The Efficacy of Two Potential Diagnostic Assays for Herpes Simplex Keratitis (HSK)
Showing all 4 trials